Carly Simon, the Grammy-winning singer-songwriter behind decades of enduring hits, has revealed that she is living with Parkinson's disease, ending years of speculation about her prolonged absence from public life. The 83-year-old musician shared the news on July 27, 2026, in a personal statement that also disclosed a recent battle with skin cancer, offering fans their most candid look yet into the health struggles that have kept one of American music's most recognizable voices largely out of view.

What Carly Simon Said

In a statement provided to People and picked up by outlets including CBS News, TODAY, ABC News and Variety, Simon addressed her fans directly, writing in part that "the truth is, I've been learning how to live with Parkinson's disease." The admission was notable both for its candor and its timing: Simon has rarely discussed her health in detail over the past several years, and her public appearances have grown increasingly rare since the mid-2020s.

Simon described the emotional dimension of the disease in vivid terms, saying the apathy that can accompany Parkinson's has been "particularly strange," comparing it to a sensation "as though the part of the brain that sends out invitations to participate in life has temporarily misplaced the guest list." It is a characteristically literary turn of phrase from an artist whose lyrics have long been celebrated for their emotional precision, and it offers a rare first-person window into a symptom of Parkinson's that receives far less public attention than tremors or stiffness: the blunting of motivation and drive that neurologists call apathy syndrome.

She closed her statement on a note of resolve, telling fans, "I have not stopped living, and I have not stopped working," signaling that despite the diagnosis she intends to remain creatively engaged.

A Diagnosis Years in the Making

According to Simon's account, her path to a Parkinson's diagnosis was long and, for a period, misdirected. Her early symptoms, including pain and stiffness in both knees and one hip, were initially attributed to arthritis, a far more common and less alarming explanation for an older adult experiencing joint trouble. Simon underwent three separate joint replacement surgeries in pursuit of relief.

It was only after those procedures failed to fully resolve her symptoms that Simon sought a more comprehensive evaluation at the Mayo Clinic, one of the most respected diagnostic centers in the United States. That evaluation ultimately produced the Parkinson's diagnosis, reframing years of physical struggle within a different and more serious medical context.

This kind of diagnostic journey is not unusual. Parkinson's disease shares early symptoms with several more common conditions, including arthritis, general age-related frailty, and even anxiety or depression, and misattribution or delayed diagnosis is a well-documented challenge in neurology. Movement disorder specialists often note that by the time hallmark symptoms like a resting tremor become obvious, the underlying neurodegeneration may have been progressing for years.

Understanding Parkinson's Disease

Parkinson's disease is a progressive neurological disorder caused by the gradual loss of dopamine-producing neurons in a region of the brain called the substantia nigra. Dopamine plays a critical role in coordinating smooth, controlled movement, and its depletion produces the disease's hallmark motor symptoms: tremor, muscle rigidity, slowed movement (known clinically as bradykinesia), and impaired balance and coordination.

But as Simon's own description makes clear, Parkinson's is not solely a movement disorder. Non-motor symptoms, including apathy, depression, anxiety, sleep disturbances, and cognitive changes, are increasingly recognized by clinicians as central features of the disease rather than side effects of coping with it. Speech changes, such as softer or more monotone speaking voice, are also common and can be especially difficult for performers and public speakers.

The disease affects an estimated 1 million people in the United States and nearly 10 million people worldwide, according to Parkinson's advocacy organizations, with prevalence rising sharply with age. Most diagnoses occur after age 60, though a meaningful subset of patients experience early-onset Parkinson's before 50. There is currently no cure, but a range of treatments, including dopamine-replacement medications, deep brain stimulation, and physical and speech therapy, can meaningfully manage symptoms and slow their impact on daily life.

A Second Diagnosis: Basal Cell Carcinoma

Simon's statement also revealed that she was treated for basal cell carcinoma, the most common form of skin cancer. Basal cell carcinomas develop in the skin's basal cells and are generally slow-growing and highly treatable, especially when caught early, but treatment can require surgical removal that leaves visible scarring, particularly when the cancer develops on the face.

Simon said the surgery altered her appearance and left her more self-conscious about being seen in public, adding another layer of explanation for her reduced visibility in recent years. Taken together with the Parkinson's diagnosis, the disclosure paints a picture of an artist managing two significant, unrelated health challenges simultaneously while largely keeping that burden private.

Carly Simon's Place in Music History

Simon's career spans more than five decades and includes some of the most enduring songs in American popular music, including "You're So Vain," "Anticipation," and "Nobody Does It Better," the theme to the James Bond film "The Spy Who Loved Me." She has won a Grammy, an Oscar, and a Golden Globe, and was inducted into the Songwriters Hall of Fame in recognition of her decades of influence on confessional, melodically sophisticated pop songwriting.

Beyond her chart success, Simon has long been known for the literary quality of her lyrics and for cultivating an air of mystery, most famously around the enduring public guessing game over the subject of "You're So Vain." That same narrative instinct is evident in how she has chosen to describe her Parkinson's symptoms now, turning a clinical diagnosis into a piece of vivid, personal writing.

She has also battled health issues in public before. Simon has previously discussed struggles with anxiety and stage fright that shaped her decision to largely retreat from touring earlier in her career, making her current openness about a new and more serious diagnosis a continuation, in some ways, of a long and complicated relationship with public vulnerability.

How Fans and the Industry Are Reacting

News of Simon's diagnosis spread quickly across entertainment outlets and social media following the initial reports from People, CBS News, and other major outlets on July 27. Reaction from fans has centered on both concern for her health and gratitude for her candor, with many pointing to her openness as a valuable contribution to public understanding of Parkinson's, a disease that remains widely misunderstood despite its prevalence.

Public figures disclosing Parkinson's diagnoses have historically had an outsized effect on awareness and research funding. Michael J. Fox's 1998 disclosure and subsequent advocacy work through the Michael J. Fox Foundation for Parkinson's Research is frequently cited by neurologists as a turning point in both public understanding of the disease and the scale of research investment directed toward finding better treatments and, eventually, a cure. Advocacy organizations often note that celebrity disclosures tend to produce measurable, if temporary, spikes in searches for symptom information and in engagement with support and research organizations.

Why This Story Matters Beyond Celebrity News

Stories like Simon's carry weight beyond the entertainment pages because they humanize a disease that can otherwise feel abstract or purely clinical to people who have not encountered it personally. Parkinson's disproportionately affects older adults, a demographic that includes a large share of the audience that grew up with Simon's music, and her description of symptoms in plain, relatable language, rather than purely medical terminology, may help other patients and families recognize similar experiences in themselves or loved ones.

Her account of misdiagnosed arthritis is also a useful cautionary note for both patients and clinicians. Movement disorder specialists have increasingly called for greater vigilance around distinguishing early Parkinson's symptoms from more common age-related conditions, since earlier diagnosis generally allows for earlier initiation of symptom-management therapies, even though it does not change the underlying disease trajectory.

What Comes Next

Simon has not announced specific upcoming projects or public appearances following her disclosure, and it remains unclear whether she plans further public discussion of her condition or intends to become involved in Parkinson's advocacy in the way other public figures have. Given her stated intention to keep working, however, further updates from Simon or her representatives are plausible in the coming months.

In the near term, expect continued coverage from entertainment and health outlets examining both the personal and cultural dimensions of her disclosure, alongside renewed public interest in Parkinson's research and patient resources. Organizations such as the Michael J. Fox Foundation and the Parkinson's Foundation frequently see upticks in public engagement following high-profile disclosures like Simon's, and advocates will likely look to channel that attention into continued support for research funding.

The Treatment Landscape for Parkinson's Disease

While Parkinson's disease remains incurable, the range of available treatments has expanded considerably over the past two decades, and Simon's reference to medication easing her stiffness reflects a now-standard first line of therapy: dopamine-replacement drugs such as levodopa, typically paired with a second compound that helps the body deliver it more effectively to the brain. For patients whose symptoms become difficult to manage with medication alone, deep brain stimulation, a surgical procedure that implants electrodes to regulate abnormal electrical signals in the brain, has become an increasingly common option, particularly for tremor-dominant cases.

Physical therapy, speech therapy, and occupational therapy also play a central role in Parkinson's care, particularly for performers and public figures like Simon, for whom vocal control and physical presence on stage are professionally significant. Speech-language pathologists who specialize in Parkinson's often use structured vocal exercise programs designed to counteract the soft, monotone speech pattern the disease can produce, an intervention that could be especially relevant for a singer managing the condition.

Research into disease-modifying treatments, therapies that could slow or halt the underlying neurodegeneration rather than simply managing symptoms, remains an active but unresolved area of study. Several pharmaceutical companies and academic research centers are pursuing approaches targeting alpha-synuclein, a protein that forms toxic clumps in the brains of Parkinson's patients, though none have yet produced a therapy proven to alter the disease's fundamental course.

Simon's Discography and Cultural Legacy

Any account of Simon's health disclosure sits against the backdrop of a career that helped define the confessional singer-songwriter era of the 1970s. Her breakthrough album "No Secrets," which included "You're So Vain," topped the Billboard charts and cemented her as one of the defining voices of the era alongside contemporaries like Carole King and Joni Mitchell. She went on to write and perform "Nobody Does It Better" for the 1977 Bond film "The Spy Who Loved Me," a song widely regarded as one of the best entries in the franchise's theme song catalog, and later won an Academy Award for "Let the River Run" from the film "Working Girl."

Simon's songwriting has often been distinguished by its psychological candor, tackling themes of vanity, longing, and personal insecurity with a directness that was relatively uncommon in mainstream pop at the time. That same candor is evident in how she has chosen to describe her Parkinson's symptoms now, suggesting a continuity in her artistic voice even as she discusses an intensely personal medical struggle.

The Ripple Effect of Celebrity Health Disclosures

Public figures revealing serious diagnoses have historically had a measurable, if often temporary, effect on public awareness and research funding for the conditions involved. Michael J. Fox's 1998 disclosure of his own Parkinson's diagnosis, and his subsequent decision to found the Michael J. Fox Foundation for Parkinson's Research, is frequently cited by neurologists and public health researchers as one of the most consequential examples of celebrity health advocacy reshaping a disease's research funding landscape; the foundation has since directed more than a billion dollars toward Parkinson's research since its founding.

Other examples abound across different conditions: Angelina Jolie's 2013 disclosure of a preventive double mastectomy following a BRCA1 gene mutation diagnosis was linked by subsequent research to a measurable, if short-lived, increase in genetic testing referrals, a phenomenon researchers termed the "Angelina effect." Whether Simon's disclosure produces a similar, quantifiable public health response remains to be seen, but health communication researchers generally agree that disclosures from well-known cultural figures reach and resonate with audiences that more traditional public health messaging often struggles to engage.

Understanding Apathy as a Parkinson's Symptom

Simon's description of apathy, the sense that "the part of the brain that sends out invitations to participate in life has temporarily misplaced the guest list," points to a symptom category that receives comparatively little public attention relative to the disease's more visible motor symptoms. Clinically, apathy in Parkinson's is understood as a distinct neuropsychiatric symptom rather than simply a psychological reaction to physical decline, believed to stem from the same dopamine-pathway disruptions that cause motor symptoms, since dopamine also plays a central role in the brain's motivation and reward circuitry.

Neurologists who treat Parkinson's patients note that apathy is often under-recognized and under-treated, in part because it can be mistaken for depression, a related but clinically distinct condition, and in part because patients and family members may interpret reduced engagement as a natural response to physical limitations rather than a direct symptom of the disease itself requiring its own targeted management approach.

Parkinson's and the Aging Population

Simon's diagnosis arrives amid a broader demographic reality: Parkinson's disease incidence is rising globally, driven in large part by aging populations in the United States, Europe, and East Asia. Epidemiological researchers have described Parkinson's as one of the fastest-growing neurological disorders in the world by total disease burden, a trend that public health researchers attribute both to population aging and to improved diagnostic recognition of the condition in regions where it was historically underdiagnosed.

That growth has intensified research and advocacy attention on early detection tools, including emerging efforts to identify biomarkers, from imaging techniques to skin and blood tests, that could flag Parkinson's before its hallmark motor symptoms appear. Earlier detection is broadly considered valuable because it allows patients to begin symptom-management therapies sooner, even though, as with Simon's case, current treatments do not halt the disease's underlying progression.

Key Facts at a Glance

  • Carly Simon, 83, disclosed her Parkinson's diagnosis publicly on July 27, 2026.
  • Early symptoms were initially attributed to arthritis, leading to three joint replacement surgeries before the correct diagnosis emerged.
  • She was also treated for basal cell carcinoma, a common form of skin cancer.
  • Simon says medication is helping manage stiffness, though symptom severity fluctuates.
  • She has stated she intends to continue working despite the diagnosis.
"The truth is, I've been learning how to live with Parkinson's disease... I have not stopped living, and I have not stopped working." — Carly Simon

This article summarizes publicly reported developments regarding Carly Simon's health disclosure and will be updated as more information becomes available.